Myocardial Perfusion Assessment With Multidetector Computed Tomography
1 other identifier
interventional
100
1 country
1
Brief Summary
Demonstrate the ability of muti-detector computed tomography to adequately perform stress testing will result in a veritable "one-stop shop" of non-invasive cardiac imaging that is, the ability to directly visualize heart arteries with high accuracy and to simultaniously determine the hemodynamic significance of any blockages visualized.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 coronary-artery-disease
Started Feb 2009
Shorter than P25 for phase_3 coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 17, 2009
CompletedFirst Posted
Study publicly available on registry
February 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedFebruary 18, 2009
February 1, 2009
7 months
February 17, 2009
February 17, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Accuracy (Sensitivity/Specificity/Positive Predictive Value/Negative Predictive Value)
6 months
Secondary Outcomes (1)
Radiation dosimetry
6 months
Interventions
Regadenason, typical dosing
Eligibility Criteria
You may qualify if:
- Adults \>18 years of age
- Adults undergoing myocardial perfusion SPECT imaging
- Adults with suspected coronary artery disease
You may not qualify if:
- Age \<18
- Known or suspected renal insufficiency (Creatinine \<1.7 mg/dl)
- Allergy to contrast
- Inability or contraindication to lexiscan or beta blocker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tennessee Heart and Vascular Institute, P.C.lead
- General Electriccollaborator
Study Sites (1)
Tennessee Heart and Vascular Institute
Hendersonville, Tennessee, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 17, 2009
First Posted
February 18, 2009
Study Start
February 1, 2009
Primary Completion
September 1, 2009
Study Completion
September 1, 2009
Last Updated
February 18, 2009
Record last verified: 2009-02